Ntv Asset Management LLC Novo Nordisk A S Transaction History

Ntv Asset Management LLC

$731 Million
Q1 2025

A detailed history of Ntv Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ntv Asset Management LLC holds 9,954 shares of NVO stock, worth $640,738. This represents 0.09% of its overall portfolio holdings.

Number of Shares

9,954

Previous 9,206 8.13%

Holding current value

$640,738

Previous $791,000 12.64%

% of portfolio

0.09%

Previous 0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$69.3 - $90.95 $51,836 - $68,030	748 Added 8.13%	9,954 $691,000
Q4 2024 Jan 31, 2025	BUY	$85.0 - $120.04 $21,760 - $30,730	256 Added 2.86%	9,206 $791,000
Q1 2024 May 07, 2024	BUY	$102.11 - $135.92 $168,481 - $224,267	1,650 Added 22.6%	8,950 $1.15 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $17,556 - $21,090	-200 Reduced 2.67%	7,300 $755,000
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $341,025 - $748,275	3,750 Added 100.0%	7,500 $682,000
Q2 2023 Aug 02, 2023	SELL	$155.98 - $172.65 $23,397 - $25,897	-150 Reduced 3.85%	3,750 $606,000
Q4 2021 Feb 04, 2022	SELL	$95.88 - $117.08 $28,764 - $35,124	-300 Reduced 7.14%	3,900 $437,000
Q1 2020 May 06, 2020	SELL	$49.46 - $64.78 $9,892 - $12,956	-200 Reduced 4.55%	4,200 $253,000
Q3 2019 Nov 04, 2019	SELL	$47.54 - $53.43 $9,508 - $10,686	-200 Reduced 4.35%	4,400 $227,000
Q3 2018 Nov 08, 2018	SELL	$46.76 - $51.24 $28,056 - $30,744	-600 Reduced 11.54%	4,600 $217,000
Q4 2017 Feb 06, 2018	SELL	$47.53 - $53.73 $4,753 - $5,373	-100 Reduced 1.89%	5,200 $279,000
Q3 2017 Nov 06, 2017	SELL	$41.15 - $49.22 $28,805 - $34,454	-700 Reduced 11.67%	5,300 $255,000
Q2 2017 Aug 08, 2017	BUY	N/A	6,000	6,000 $257,000

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

329M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $145B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.

Account

Ntv Asset Management LLC Novo Nordisk A S Transaction History